Efficacy And Safety Of PF-00885706 For The Relief Of Symptoms In Subjects With Gastro-esophageal Reflux Disease (GERD)

NCT00730665 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

81

Enrollment

INDUSTRY

Sponsor class

Stopped This study has been placed on clinical hold by the sponsor due to operational reasons.

Conditions

Gastroesophageal Reflux Disease

Interventions

DRUG: PF-00885706
DRUG: Esomeprazole
DRUG: PF-00885706
DRUG: Esomeprazole
DRUG: PF-00885706
DRUG: Esomeprazole
DRUG: PF-00885706
DRUG: Esomeprazole
OTHER: Placebo
DRUG: Esomeprazole

Sponsor

Pfizer